In this regard, suppression of Akt activity by small molecule allosteric inhibitors [9] sensitizes many tumour cell lines to apoptotis induced by DNA damage, microtubule-binding agents, targeted therapeutics and ionizing radiation [10] suggesting that Akt inhibitors may enhance the efficacy of chemotherapy and radiotherapy in breast cancer. This evidence concerns the gene AKT1 and breast carcinoma.